Turnover: 13.64 billion EUR (2020)

Country: Ireland

Allergan plc is an Irish-based pharmaceutical company with operations in 100 countries worldwide. Its business portfolio includes several therapeutic areas, namely central nervous system, ophthalmology, medical aesthetics and dermatology, gastroenterology, women's health, urology and anti-infectives.

In France, more than 500 employees work for the Allergan group, both in the sales office located in La Défense in Paris and in its R&D center in Paris

In 2007, the group acquired the Cornéal laboratory for 170 million euros, resulting in the wrinkle-filling treatment Juvederm.

News

Medicine, Allergan Aesthetics launches training center for healthcare professionals 26/06/2023

Inauguration of Allergan Aesthetics' Center of Excellence in Italy, specifically in Rome. This center represents the first and only space completely dedicated to both theoretical and practical training of healthcare professionals. Its foundation is supported by the expertise of a multidisciplinary scientific committee composed of 21 nationally and internationally renowned experts. The main goal of the center is to offer high-quality training to healthcare professionals through 4 complementary curricula in order to ensure maximum satisfaction of their patients.

Financial Data

DUNS: 312856917

Legal Name: ALLERGAN FRANCE

Address: 1 PASSERELLE DES REFLETS TOUR CBX, 92400 COURBEVOIE

Number of employees: 0 salarié (2022)

Capital: 133 170 EUR


Financial Data:

Year 2021 2020 2019 2018 2017 2016
Turnover 209 385 039 194 199 277 215 941 842 212 713 919 218 592 144 209 613 514
Gross margin (€) 75 370 829 65 477 206 66 902 246 68 671 802 69 205 739 68 775 615
EBITDA (€) 8 791 125 5 897 779 8 116 248 9 039 148 6 914 538 8 134 428
Operating profit (€) 10 262 226 7 594 014 9 608 070 9 603 984 9 886 324 11 733 463
Net profit (€) 4 119 380 3 258 017 3 277 610 3 621 350 4 205 342 5 487 478
Turnover growth rate (%) 7,8 -10,1 1,5 -2,7 4,3 7,1
Ebitda margin rate (%) 4,2 3 3,8 4,2 3,2 3,9
Operating margin rate (%) 4,9 3,9 4,4 4,5 4,5 5,6
Working Capital (turnover days) -28,3 -31,4 -19,5 -17,7 13,8 12,3
Working Capital requirements (turnover days) 16,4 1,8 11,1 12,3 13,5 17,6
Net margin (%) 2 1,7 1,5 1,7 1,9 2,6
Added value / Turnover (%) 24 24 20,6 22,2 20,9 21,4
Wages and social charges (€) 29 742 303 29 280 141 27 890 951 27 830 122 28 321 529 27 251 398
Salaries / Turnover (%) 14,2 15,1 12,9 13,1 13 13

Company Managers:

Position First Name Last Name Age Linkedin
Président Stephane, Charles Lassignardie 54
Directeur général Thierry, Georges Souchon 60

Studies mentioning this company

> Besoin de plus d'information sur cette entreprise (SWOT, PESTEL, son marché) ? Demandez à SectorGPT (gratuit)

 

Ask Sector-GPT  

Sector-GPT est la première IA dédiée aux informations sectorielles.